Organon launches two denosumab biosimilars in Canada
Go back to Organon launches two denosumab biosimilars in Canada| (NYSE: OGN) | Delayed: 13.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.72 | 52 Week High | $8.00 | |||
| Open | $13.72 | 52 Week Low | $8.00 | |||
| Day High | $13.72 | P/E | N/A | |||
| Day Low | $13.72 | EPS | $0.00 | |||
| Volume | 859 | |||||
